Page 6 - Bioscience Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market-Advanced regulatory and seed scale-up program for omega-3 Camelina-E3902 oil trait in Camelina cleared by regulatory authority for planting in Canada-Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update WOBURN, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricult

Item 1.01 Entry into a Material Definitive Agreement. On March 27, 2024, INVO Bioscience, Inc., a Nevada corporation entered into a purchase agreement with Triton Funds...

-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market-Advanced regulatory and seed scale-up program for omega-3 Camelina-E3902 oil trait in Camelina cleared...

Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.12.

-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market-Advanced regulatory and seed scale-up program fo...